Dawei Huang
- Gastroenterology top 10%
- Gastrointestinal motility and disorders 2
- Geriatrics and Gerontology top 10%
-
- Traditional Chinese Medicine Studies 3
-
- MicroRNA in disease regulation 3
- Cancer, Lipids, and Metabolism 3
-
- RNA modifications and cancer 3
- Peroxisome Proliferator-Activated Receptors 2
-
- Lipoproteins and Cardiovascular Health 2
-
- Peptidase Inhibition and Analysis 2
Dawei Huang
31 papers receiving 601 citations
Peers
Comparison fields: 5 of 92
- Gastroenterology 50
- Geriatrics and Gerontology 30
- Complementary and alternative medicine 58
- Cancer Research 82
- Neurology 81
Countries citing papers authored by Dawei Huang
This map shows the geographic impact of Dawei Huang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dawei Huang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dawei Huang more than expected).
Fields of papers citing papers by Dawei Huang
This network shows the impact of papers produced by Dawei Huang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dawei Huang. The network helps show where Dawei Huang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Dawei Huang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 1 | |
| 3 | 2021 | 22 | |
| 4 | 2021 | 13 | |
| 5 | 2020 | 22 | |
| 6 | 2020 | 3 | |
| 7 | 2020 | 5 | |
| 8 | 2020 | 7 | |
| 9 | 2020 | 13 | |
| 10 | 2019 | 17 | |
| 11 | 2018 | 16 | |
| 12 | 2015 | 50 | |
| 13 | 2015 | 25 | |
| 14 | Synthesis, Biological Evaluation and Molecular Modeling of Cyclic Tetrapeptide Based Inhibitors HDAC | 2012 | 5 |
| 15 | 2011 | 73 | |
| 16 | 2009 | 4 | |
| 17 | 2006 | 28 | |
| 18 | 2005 | 28 | |
| 19 | 2002 | 46 | |
| 20 | 1993 | 7 |
About Dawei Huang
Dawei Huang is a scholar working on Complementary and alternative medicine, Cancer Research and Gastroenterology, having authored 32 papers that have together received 609 indexed citations. Recurring topics across this work include MicroRNA in disease regulation (3 papers), Traditional Chinese Medicine Studies (3 papers), Cancer, Lipids, and Metabolism (3 papers), RNA modifications and cancer (3 papers), Gastrointestinal motility and disorders (2 papers), Lipoproteins and Cardiovascular Health (2 papers), Peptidase Inhibition and Analysis (2 papers) and Peroxisome Proliferator-Activated Receptors (2 papers). The work is most often cited by research in Gastroenterology (50 citations), Geriatrics and Gerontology (30 citations) and Complementary and alternative medicine (58 citations). Dawei Huang has collaborated with scholars based in China, Taiwan and United Kingdom. Frequent co-authors include Szu‐Chuan Shen, Shanming Ruan, Di Qu, Y. Martin Lo, Wen‐Chung Huang, James Swi‐Bea Wu, Kuo‐Chang Huang, Sheng‐Hong Tseng, Lu Yang and Chang‐Jiang Zou. Their work appears in journals such as Nature Communications, PLoS ONE and Journal of Agricultural and Food Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.